Literature DB >> 18698324

NG2 antigen is expressed in CD34+ HPCs and plasmacytoid dendritic cell precursors: is NG2 expression in leukemia dependent on the target cell where leukemogenesis is triggered?

C Bueno, R Montes, L Martín, I Prat, M C Hernandez, A Orfao, P Menendez.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18698324     DOI： 10.1038/leu.2008.134

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  21 in total

1.  Cord blood-derived CD34+ hematopoietic cells with low mitochondrial mass are enriched in hematopoietic repopulating stem cell function.

Authors:  Damia Romero-Moya; Clara Bueno; Rosa Montes; Oscar Navarro-Montero; Francisco J Iborra; Luis Carlos López; Miguel Martin; Pablo Menendez
Journal:  Haematologica       Date:  2013-01-24       Impact factor: 9.941

2.  Role of BRD4 in hematopoietic differentiation of embryonic stem cells.

Authors:  Ramon M Rodriguez; Beatriz Suarez-Alvarez; Ruben Salvanés; Covadonga Huidobro; Estela G Toraño; Jose L Garcia-Perez; Carlos Lopez-Larrea; Agustin F Fernandez; Clara Bueno; Pablo Menendez; Mario F Fraga
Journal:  Epigenetics       Date:  2014-01-20       Impact factor: 4.528

Review 3.  Revisiting the biology of infant t(4;11)/MLL-AF4+ B-cell acute lymphoblastic leukemia.

Authors:  Alejandra Sanjuan-Pla; Clara Bueno; Cristina Prieto; Pamela Acha; Ronald W Stam; Rolf Marschalek; Pablo Menéndez
Journal:  Blood       Date:  2015-10-13       Impact factor: 22.113

4.  The ROCK inhibitor Y-27632 negatively affects the expansion/survival of both fresh and cryopreserved cord blood-derived CD34+ hematopoietic progenitor cells: Y-27632 negatively affects the expansion/survival of CD34+HSPCs.

Authors:  Clara Bueno; Rosa Montes; Pablo Menendez
Journal:  Stem Cell Rev Rep       Date:  2010-06       Impact factor: 5.739

Review 5.  Antithetic roles of proteoglycans in cancer.

Authors:  Elena Garusi; Silvia Rossi; Roberto Perris
Journal:  Cell Mol Life Sci       Date:  2011-10-02       Impact factor: 9.261

6.  Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.

Authors:  Le-Le Lu; Jing Sun; Jie-Juan Lai; Yan Jiang; Lian-Hua Bai; Lei-Da Zhang
Journal:  World J Gastroenterol       Date:  2015-06-07       Impact factor: 5.742

7.  Ligand-independent FLT3 activation does not cooperate with MLL-AF4 to immortalize/transform cord blood CD34+ cells.

Authors:  R Montes; V Ayllón; C Prieto; A Bursen; C Prelle; D Romero-Moya; P J Real; O Navarro-Montero; C Chillón; R Marschalek; C Bueno; P Menendez
Journal:  Leukemia       Date:  2013-11-18       Impact factor: 11.528

8.  A promoter DNA demethylation landscape of human hematopoietic differentiation.

Authors:  Vincenzo Calvanese; Agustín F Fernández; Rocío G Urdinguio; Beatriz Suárez-Alvarez; Cristina Mangas; Vicente Pérez-García; Clara Bueno; Rosa Montes; Verónica Ramos-Mejía; Pablo Martínez-Camblor; Cecilia Ferrero; Yassen Assenov; Christoph Bock; Pablo Menendez; Ana Clara Carrera; Carlos Lopez-Larrea; Mario F Fraga
Journal:  Nucleic Acids Res       Date:  2011-09-12       Impact factor: 16.971

9.  Residual expression of the reprogramming factors prevents differentiation of iPSC generated from human fibroblasts and cord blood CD34+ progenitors.

Authors:  Verónica Ramos-Mejía; Rosa Montes; Clara Bueno; Verónica Ayllón; Pedro J Real; René Rodríguez; Pablo Menendez
Journal:  PLoS One       Date:  2012-04-24       Impact factor: 3.240

Review 10.  Theranostic impact of NG2/CSPG4 proteoglycan in cancer.

Authors:  Pier Andrea Nicolosi; Alice Dallatomasina; Roberto Perris
Journal:  Theranostics       Date:  2015-02-15       Impact factor: 11.556
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.